4//SEC Filing
Parkinson David Ross 4
Accession 0000950172-24-000130
CIK 0001633932other
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 12:27 PM ET
Size
5.3 KB
Accession
0000950172-24-000130
Insider Transaction Report
Form 4
ESSA Pharma Inc.EPIX
Parkinson David Ross
DirectorPresident and CEO
Transactions
- Award
Options
2024-03-25+350,000→ 350,000 totalExercise: $9.04From: 2025-03-25Exp: 2034-03-25→ Common Shares (350,000 underlying)
Footnotes (1)
- [F1]Stock options vest and become exercisable over four years as follows: (i) 25% of the underlying shares vest one year after the grant date; and (ii) 75% of the remaining underlying shares vest in equal monthly installments over the following three years.
Documents
Issuer
ESSA Pharma Inc.
CIK 0001633932
Entity typeother
Related Parties
1- filerCIK 0001451935
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 12:27 PM ET
- Size
- 5.3 KB